Go Deep
Jade Biosciences, Inc.
Jade Biosciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,655 | -7.0 | 1.94 | 0.00 | 1,278.04 |
| Oct 2026 | 20,650 | -7.0 | 1.94 | 0.00 | 1,276.09 |
| Oct 2026 | 20,570 | -7.2 | 1.99 | 0.00 | 1,306.66 |
| Oct 2026 | 20,643 | -7.0 | 1.95 | 0.00 | 1,275.81 |
| Oct 2026 | 20,552 | -7.2 | 2.00 | 0.00 | 1,311.31 |
| Oct 2026 | 20,293 | -7.7 | 2.15 | 0.00 | 1,408.97 |
| Oct 2026 | 20,225 | -7.9 | 2.19 | 0.00 | 1,431.03 |
| Oct 2026 | 20,281 | -7.8 | 2.16 | 0.00 | 1,407.37 |
| Oct 2026 | 20,361 | -7.6 | 2.11 | 0.00 | 1,382.87 |
Jade Biosciences, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -55,765,000.0 | -40,368,000.0 | -31,932,000.0 | -25,175,000.0 |
| EPS | -0.8 | -0.6 | — | -0.5 |
Jade Biosciences, Inc. Revenue & Profit: Last 1 Year
| Line Item | Dec 2025 |
|---|---|
| Revenue | 0.0 |
| Net Profit | -127,410,000.0 |
| EPS | -3.2 |
Jade Biosciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 349,781,000.0 | 72,799,000.0 |
| Total Liabilities | 17,263,000.0 | 119,598,000.0 |
| Total Equity | 332,518,000.0 | -46,799,000.0 |
Owes vs Owns
Jade Biosciences, Inc. owed $0.07 for every $1 it owned in Jun 2026, down from $1.64 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 0.07× | 0.05× | 1.64× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Jade Biosciences, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 96.1%Other assets 3.6%
How it's funded — Dec 2025
Payables 0.6%Other liabilities 4.1%Shareholders' equity 95.1%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 336.2 | 69.4 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.9 | 0.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 12.7 | 3.4 |
| Liabilities & equity | ||
| Short-term debt | 0.0 | 0.0 |
| Long-term debt | 0.7 | 107.6 |
| Payables | 2.2 | 1.3 |
| Other liabilities | 14.4 | 10.7 |
| Shareholders' equity | 332.5 | -46.8 |
| Net tangible assets | 332.5 | -46.8 |
Jade Biosciences, Inc. Cash Flow
| Line Item | Dec 2025 |
|---|---|
| Operating Activities | -94,689,000.0 |
| Investing Activities | -247,006,000.0 |
| Financing Activities | 360,768,000.0 |